These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15685843)

  • 1. Potential effects of antidepressant agents on the growth and development of children and adolescents.
    Nardi DA; Barrett S
    J Psychosoc Nurs Ment Health Serv; 2005 Jan; 43(1):22-35. PubMed ID: 15685843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facing the evidence: antidepressant treatment in children and adolescents.
    Garland EJ
    CMAJ; 2004 Feb; 170(4):489-91. PubMed ID: 14970097
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of antidepressant drug treatment in children and adolescents.
    Henry A; Kisicki MD; Varley C
    Mol Psychiatry; 2012 Dec; 17(12):1186-93. PubMed ID: 22064376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA questions antidepressant safety for children.
    Oransky I
    Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000
    [No Abstract]   [Full Text] [Related]  

  • 7. UK psychiatrists question SSRI warnings for under-18s.
    Meek C
    CMAJ; 2004 Feb; 170(4):455. PubMed ID: 14970082
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?
    Healy D
    Can J Psychiatry; 2009 Feb; 54(2):69-71; discussion 76-7. PubMed ID: 19254434
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of regulatory warnings on antidepressant prescribing for children and adolescents.
    Kurian BT; Ray WA; Arbogast PG; Fuchs DC; Dudley JA; Cooper WO
    Arch Pediatr Adolesc Med; 2007 Jul; 161(7):690-6. PubMed ID: 17606833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth suicide trends place SSRIs in spotlight.
    Behav Healthc Tomorrow; 2004 Feb; 13(1):42-5. PubMed ID: 15002199
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do SSRIs cause suicide in children? The evidence is underwhelming.
    Bostwick JM
    J Clin Psychol; 2006 Feb; 62(2):235-41. PubMed ID: 16342291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of major depression in adolescents: weighing the evidence of risk and benefit in light of black box warnings.
    Lovrin M
    J Child Adolesc Psychiatr Nurs; 2009 May; 22(2):63-8. PubMed ID: 19490276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal risk from TADS study was higher than it first appeared.
    Högberg G; Antonuccio DO; Healy D
    Int J Risk Saf Med; 2015; 27(2):85-91. PubMed ID: 26410011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ethics of paediatric anti-depressant use: erring on the side of caution.
    Shearer MC; Bermingham SL
    J Med Ethics; 2008 Oct; 34(10):710-4. PubMed ID: 18827099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between antidepressant prescription rates and rate of early adolescent suicide.
    Gibbons RD; Hur K; Bhaumik DK; Mann JJ
    Am J Psychiatry; 2006 Nov; 163(11):1898-904. PubMed ID: 17074941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antidepressant agents in the therapy of severe depression in adolescents].
    Marttunen M; Aalberg V
    Duodecim; 1999; 115(1):36-44. PubMed ID: 11830858
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.